Discover 1,378 paid clinical trials in St. Louis, Missouri. Search by condition or phase to find a research study near you that matches your needs across various therapeutic areas.
St. Louis currently offers medical research opportunities for a variety of conditions, including cancer, heart disease, prurigo nodularis, and pain management. The city's leading institutions are actively recruiting participants, offering opportunities for healthy volunteers in paid studies, as well as those seeking trials for specific health conditions, providing access to innovative treatments and advanced medical care.
Filter
2
Filter results
Results: 1,378
Active & Responsive
Lupus Landmark Study: A Prospective Registry and Biorepository
Location: St Louis MO, Indianapolis IN, Nashville TN, Chicago IL,
Sponsor: Mayo Clinic
Sex: All
Age: 18+
Code: NCT04363684
Recruiting
Active & Responsive
Tied Tube Trial in Glaucoma Surgery
for
Glaucoma Eye, Ahmed Glaucoma Valve Implantation
Location: Saint Louis MO
Sponsor: Washington University School of Medicine
Sex: All
Age: 18+
Code: NCT05685485
Recruiting
Active & Responsive
Cardiac RADIoablation Versus Repeat Catheter Ablation: a Pivotal Randomized Clinical Trial Evaluating Safety and Efficacy for Patients With High-risk Refractory Ventricular Tachycardia (RADIATE-VT)
for
Tachycardia, Ventricular
Location: St Louis MO, Columbia MO, Nashville TN, Rochester MN,
Sponsor: Varian, a Siemens Healthineers Company
Sex: All
Age: 18+
Code: NCT05765175
Recruiting
Active & Responsive
Decreasing Emergence Agitation With Personalized Music
for
Surgical Procedure, Unspecified
Location: Saint Louis MO, Stanford CA
Sponsor: Stanford University
Sex: All
Age: 3 - 9
Code: NCT05044832
Recruiting
Interested in new trials?
Get alerts for new trials in your area by subscribing now
Active & Responsive
Light Therapy for Obsessive-compulsive Disorder (OCD)
for
OCD
Location: St Louis MO
Sponsor: Washington University School of Medicine
Sex: All
Age: 17 - 35
Code: NCT06720090
Early_phase1, Recruiting
Active & Responsive
Solid Tumor Analysis for HLA Loss of Heterozygosity (LOH) and Apheresis for CAR T- Cell Manufacturing
for
Solid Tumor, Adult, Colorectal Cancer,
Location: St Louis MO, Nashville TN, Rochester MN, Columbus OH,
Sponsor: A2 Biotherapeutics Inc.
Sex: All
Age: 18+
Code: NCT04981119
Recruiting
Active & Responsive
Gene Correction in Autologous CD34+ Hematopoietic Stem Cells (HbS to HbA) to Treat Severe Sickle Cell Disease
for
Sickle Cell Disease
Location: St Louis MO, Columbus OH, New York NY, Los Angeles CA,
Sponsor: Kamau Therapeutics
Sex: All
Age: 12 - 50
Code: NCT04819841
Phase1, Phase2, Recruiting
Active & Responsive
A Study to Evaluate the Safety and Efficacy of Mesothelin-Targeting Logic-gated CAR T, in Participants With Solid Tumors That Express MSLN and Have Lost HLA-A*02 Expression
for
Solid Tumor, Adult, Colorectal Cancer, NSCLC,
Location: St Louis MO, Nashville TN, Rochester MN, Columbus OH,
Sponsor: A2 Biotherapeutics Inc.
Sex: All
Age: 18+
Code: NCT06051695
Phase1, Phase2, Recruiting
Active & Responsive
Interferon-γ (IFN-γ) With Donor Leukocyte Infusion to Treat Relapsed Acute Myeloid Leukemia and Myelodysplastic Syndromes Post Allogeneic Hematopoietic Stem Cell Transplantation
for
Acute Myeloid Leukemia, Myelodysplastic Syndromes
Location: St Louis MO, Pittsburgh PA, Seattle WA
Sponsor: Sawa Ito, MD
Sex: All
Age: 18+
Code: NCT06529731
Phase2, Recruiting
Active & Responsive
BradycArdia paCemaKer With AV Interval Modulation for Blood prEssure treAtmenT
EPIK-P4: A Phase II Single-arm Study to Assess the Efficacy, Safety and Pharmacokinetics of Alpelisib (BYL719) in Pediatric and Adult Patients With PIK3CA-related Overgrowth Spectrum (PROS)
for
PIK3CA-related Overgrowth Spectrum (PROS)
Location: St Louis MO, Cincinnati OH, Columbus OH, Pittsburgh PA,
Sponsor: Novartis Pharmaceuticals
Sex: All
Age: 2 - 70+
Code: NCT06997588
Phase2, Recruiting
Active & Responsive
Study of S-606001 as an Add-on to Enzyme Replacement Therapy (ERT) in Participants With Late-onset Pompe Disease (LOPD)
for
Pompe Disease
Location: St Louis MO, Cincinnati OH, Atlanta GA, Pittsburgh PA,
Sponsor: Shionogi
Sex: All
Age: 18+
Code: NCT07123155
Phase2, Recruiting
Active & Responsive
Safety, Tolerability, Pharmacodynamic, Efficacy, and Pharmacokinetic Study of DYNE-101 in Participants With Myotonic Dystrophy Type 1
for
Myotonic Dystrophy Type 1 (DM1)
Location: St Louis MO, Iowa City IA, Indianapolis IN, Denton TX,
Sponsor: Dyne Therapeutics
Sex: All
Age: 18 - 65
Code: NCT05481879
Phase1, Phase2, Recruiting
Active & Responsive
Study of CP-383 in Patients With Advanced or Metastatic Solid Tumors
for
Solid Tumor Malignancies, Colorectal Carcinoma,
Location: St Louis MO, Denver CO, Omaha NE, Grand Rapids MI,
Sponsor: Tasca Therapeutics
Sex: All
Age: 18+
Code: NCT07030257
Phase1, Phase2, Recruiting
Active & Responsive
SIGMA (Safusidenib in IDH1 Mutant Glioma Maintenance)
for
Glioma, Astrocytoma, Grade IV, IDH1-mutant Glioma,
Location: St Louis MO, Indianapolis IN, Kansas City KS,